Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
2.850
-0.320 (-10.09%)
At close: May 8, 2026, 4:00 PM EDT
2.860
+0.010 (0.35%)
After-hours: May 8, 2026, 7:52 PM EDT
Enveric Biosciences Employees
As of December 31, 2025, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,021,912
Market Cap
5.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 0 | - | 5 | 1 |
| Dec 31, 2024 | 6 | -1 | -14.29% | 5 | 1 |
| Dec 31, 2023 | 7 | -19 | -73.08% | 7 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 25 | 1 |
| Dec 31, 2021 | 24 | 21 | 700.00% | 23 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| FibroBiologics | 15 |
| BioRestorative Therapies | 14 |
| Dermata Therapeutics | 9 |
| MetaVia | 8 |
| CNS Pharmaceuticals | 5 |
ENVB News
- 4 days ago - Enveric Biosciences highlights preclinical data for EB-003 - TheFly
- 4 days ago - Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model - Business Wire
- 9 days ago - Enveric Biosciences trading resumes - TheFly
- 9 days ago - Enveric Biosciences trading halted, volatility trading pause - TheFly
- 11 days ago - Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors - PRNewsWire
- 15 days ago - Enveric Biosciences files to sell 6.82M shares of common stock - TheFly
- 18 days ago - 3 Penny Stocks to Watch Now, 4/21/26 - TipRanks
- 18 days ago - Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum - Business Wire